<DOC>
	<DOCNO>NCT01234116</DOCNO>
	<brief_summary>Objective : The objective study determine safety tolerability Post-exposure Prophylaxis ( PEP ) regimen Truvada + Kaletra among health care worker ( HCWs ) Henry Ford Hospital . Hypothesis : Raltegravir safe well tolerate compare Kaletra , combination Truvada , assess review completion rate PEP also review complete safety data .</brief_summary>
	<brief_title>Post-Exposure Prophylaxis Health Care Workers</brief_title>
	<detailed_description>Health Care Workers occupational exposure blood risk HIV infection . Prevention blood exposure , safe practice , barrier precaution , safer needle device , innovation , best way prevent infection HIV bloodborne pathogen . Though strategy successful reduce frequency blood exposure needlestick injury past decade , hazard eliminate . As December 2001 , CDC receive voluntary report 57 documented case HIV seroconversion temporally associate occupational exposure HIV among U.S. health care personnel . An additional 138 infection among health care personnel consider possible case occupational transmission . Because cure effective vaccine HIV , optimal post exposure care , include administration antiretroviral drug prevent HIV infection , remain high priority protect health care worker .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Adult ( least 18 year age ) employee HFH History occupational exposure bodily fluid Negative HIV test The ability understand write informed consent form , must obtain prior initiation study procedure Positive pregnancy test Females breastfeed History renal disease Contraindication treat patient component PEP regimen Greater one dose PEP medication exposure event</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Post exposure prophylaxis</keyword>
	<keyword>Health Care Workers</keyword>
</DOC>